Michael Lee, MD - University of Minnesota Medical Center
 
Print
Michael Lee, MD
Michael Lee, MD
Request Appointment
Eye (Ophthalmology) Clinic
Phillips-Wangensteen Building
Ninth Floor, Clinic 9A
516 Delaware St.SE
Minneapolis, MN 55455
612-625-4400
 

Sees Patients at:

Medical Title:

Academic Appointments:

Services:

Specialties:

Clinical Interests:

Education:

Board Certifications:

U.S. News & World Report 2012 Top Doctor

Best Teaching Faculty, Department of Ophthalmology, University of Minnesota (2009, 20010)

Achievement Award, American Academy of Ophthalmology (2009)

Reinhardt L. and Ruth H. Schmidtke Chair in Neuro-Ophthalmology (2005)

World Class Service Award, Cleveland Clinic Foundation (2005)

Distinguished Teaching and Service Award, Massachusetts Eye and Ear Infirmary (2002)

Society of Heed Fellows Fellowship Award (2001)

Phi Beta Kappa, Johns Hopkins University (1992)

Eagle Scout (1988)

Berg K, Lee MS. Postoperative visual loss following ocular and non-ocular surgery, Clinical Ophthalmology, 2010;4:531-46.

Eichhorn K, Harrison AR, Bothun ED, McLoon LK, Lee MS. Ocular treatment of thyroid eye disease. Expert Rev Ophthalmol 2010;5:313-25.

Lee MS, Harrison AR, Grossman DS, Sloan FA. Risk of glaucoma among patients with benign essential blepharospasm, Ophthal Plast Reconstr Surg, 2010 Aug 9. [Epub ahead of print]

Lee MS, McKinney A, Brace JR, Santacruz K. Clinical and imaging features of fludarabine neurotoxicity. J Neuro-ophthalmol 2010;30:37-41.

Lee MS,* Smith S, Galor A, Hoffman G. Antiplatelet and anticoagulant therapy in giant cell arteritis. Arthritis Rheum, 2006 Oct;54(10):3306-9.

Harrison A, Berbos Z, Zaldivar R, Anderson B, Semmer A, Lee MS, McLoon L. Modulating neuromuscular junction density changes in botulinum-toxin treated orbicularis oculi muscle. Invest Ophthalmol Vis Sci, in press.

Berg K, Nelson B, Harrison AR, McLoon LK, Lee MS.* Pegylated interferon alpha-associated optic neuropathy, J Neuroophthalmol. 2010;30:117-22.

Alcalá-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH, McLoon LK. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO and NT-4 to the CNS. J Drug Targeting, 2010;18:179-90.

Saylor M, McLoon LK, Harrison AR, Lee MS* Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 2009;127:402-6.

Lee MS, Volpe NJ. Double Vision. Curr Treat Options in Neurol 2000;3(4):383-88.